3Bodine SC, Stitt TN, Gonzalez M, et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol. 2001 ; 3(11 ): 1014-1019.
4Pallafacchina G, Calabria E, Serrano AL, et al. A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc Natl Acad Sci U S A. 2002; 99(14):9213-9218.
5Nader GA, McLoughlin T J, Esser KA.mTOR function in skeletal muscle hypertrophy: increased ribosomal RNA via cell cycle regulators.Am J Physiol Cell Physiol. 2005; 289(6):C1457-1465.
6Stokoe D, Stephens LR, Copeland T, et al. Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science. 1997; 277(5325):567-570.
7Schmelzle T, Hall MN. TOR, a central controller of cell growth. Cell. 2000; 103(2):253-262.
8Ohanna M, Sobering AK, Lapointe T, et al.Atrophy of S6K1(-/-) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control. Nat Cell Biol. 2005; 7(3):286-294.
9Bodine SC.mTOR signaling and the molecular adaptation to resistance exercise.Med Sci Sports Exerc. 2006; 38(11):1950-1957.
10Nave BT, Ouwens M, Withers D J, et al.Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation.Biochem J. 1999; 344 Pt 2:427-431.
